Evidence map›Paper›PMID 33244667›Full record

ArticleThe AAPS journal2020

Correction to: Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective.

Arian Emami Riedmaier, Kevin DeMent, James Huckle, Phil Bransford, Cordula Stillhart, Richard Lloyd, Ravindra Alluri, Sumit Basu, Yuan Chen, Varsha Dhamankar and 12 more

Abstract readPublished Erratum
In one paragraph

Article in The AAPS journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Arian Emami RiedmaierDMPK and Translational Modeling, AbbVie Inc., North Chicago, Illinois, USA. arian.emamiriedmaier@abbvie.com.
Kevin DeMentGlobal DMPK, Takeda Pharmaceutical Co., Ltd., San Diego, California, USA.
James HuckleDrug Product Technology, Amgen, Thousand Oaks, California, USA.
Phil BransfordModeling & Informatics, Vertex Pharmaceuticals, Boston, Massachusetts, USA.
Cordula StillhartPharmaceutical R&D, Formulation & Process Sciences, F.Hoffmann-La Roche Ltd., Basel, Switzerland.
Richard LloydComputational & Modelling Sciences, Platform Technology Sci-ences, GlaxoSmithKline R&D, Ware, Hertfordshire, UK.
Ravindra AlluriClinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.
Sumit BasuPharmacokinetic, Pharmacodynamic and Drug Metabolism-Quantitative Pharmacology and Pharmacometrics (PPDM-QP2),Merck & Co, Inc., West Point, Pennsylvania, USA.
Yuan ChenDepartment of Drug Metabolism and Pharmacokinetics, Genentech, South San Francisco, California, USA.
Varsha DhamankarFormulation Development, Vertex Pharmaceuticals, Boston, Massachusetts, USA.
Stephanie DoddChemical & Pharmaceutical Profiling, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.
Priyanka KulkarniDepartment of Pharmacokinetics and Drug Metabolism, AmgenInc, Cambridge, Massachusetts, USA.
Andrés Olivares-MoralesPharmaceutical Sciences, Roche Pharmaceutical Research andEarly Development, Roche Innovation Center, Basel, Switzerland.
Chi-Chi PengDepartment of Pharmacokinetics and Drug Metabolism, AmgenInc, Cambridge, Massachusetts, USA.
Xavier PepinNew Modalities and Parenteral Development, PharmaceuticalTechnology & Development, Operations, AstraZeneca, Maccles-field, UK.
Xiaojun RenModeling & Simulation, PK Sciences, Novartis Institutes of Biomedical Research, East Hanover, New Jersey, USA.
Thuy TranComputational & Modelling Sciences, Platform Technology Sci-ences, GlaxoSmithKline R&D, Collegeville, Pennsylvania, USA.
Christophe TistaertPharmaceutical Sciences, Janssen Research & Development, Beerse, Belgium.
Tycho HeimbachPBPK & Biopharmaceutics, Novartis Institutes of Biomedical Research, Wayne, New Jersey, USA.
Filippos KesisoglouPharmaceutical Sciences, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Christian WagnerPharmaceutical Technologies, Chemical and Pharmaceutical De-velopment, Merck Healthcare KGaA, Darmstadt, Germany.
Neil ParrottPharmaceutical Sciences, Roche Pharmaceutical Research andEarly Development, Roche Innovation Center, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An Erratum to this paper has been published: https://doi.org/10.1208/s12248-020-00535-z.

Identifiers

PMID33244667
PMCPMC7852959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.